Lamotrigine inhibition of glutamate release from isolated cerebrocortical nerve terminals (synaptosomes) by suppression of voltage-activated calcium channel activity.
about
Glutamatergic substrates of drug addiction and alcoholismActivation of group II metabotropic glutamate receptors induces depotentiation in amygdala slices and reduces fear-potentiated startle in rats.Lamotrigine update and its use in mood disorders.A double-blind, placebo-controlled trial of lamotrigine for pathological skin picking: treatment efficacy and neurocognitive predictors of responseFronto-limbic dysfunction in mania pre-treatment and persistent amygdala over-activity post-treatment in pediatric bipolar disorder.Attenuation of the effects of corticosteroids on declarative memory with lamotrigine.A randomized, double-blind, placebo-controlled, trial of lamotrigine therapy in bipolar disorder, depressed or mixed phase and cocaine dependence.Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy.Lamotrigine and its applications in the treatment of epilepsy and other neurological and psychiatric disorders.Effects of topiramate and other anti-glutamatergic drugs on the acute intoxicating actions of ethanol in mice: modulation by genetic strain and stress.Neuroprotection of lamotrigine on hypoxic-ischemic brain damage in neonatal rats: Relations to administration time and doses.Glutamate and reinstatement.Glutamatergic medications for the treatment of drug and behavioral addictions.Investigating psychotropic properties of antiepileptic drugs.Pharmacological upregulation of h-channels reduces the excitability of pyramidal neuron dendrites.Impaired motor control in patients with benign focal epilepsy of childhood.Lamotrigine pharmacokinetic/pharmacodynamic modelling in rats.A comparison of the glutamate release inhibition and anti-allodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain.Effects of lamotrigine in patients with bipolar disorder and alcohol dependence.
P2860
Q24648924-79CE7FDD-46AE-4A42-9AA2-201DA02128B0Q30501683-0DB94E59-3BCA-4AAD-9134-F74356AE4BBFQ34615607-B30D0AAE-1FED-4F3A-A601-19917049565DQ35211785-6C98D801-09F1-4725-BA52-4129641732B9Q35217342-567F09C4-4C7E-465B-B13E-F02AD30C9BE0Q35616169-84DFE429-3CE0-4D4C-AD91-DE490ECD4911Q36234288-385FF0A7-A127-4DFD-A752-E46791891515Q36662898-0461E47F-4DC3-494B-80F1-A7497955F0D2Q36673011-23C9F252-8BC1-4A7A-A661-660F138D0AB6Q37159920-17ACB4D1-2894-4EC0-8271-415E6DBC4B15Q37290670-AE1AE3CC-AA56-4D8D-88C9-A435026BC2DCQ37373960-F56ADE80-E389-4AED-B38F-A7944F6B060CQ37871133-073D4089-CC9C-401E-8FED-4569FCEB8B6CQ38112212-5D8DC3DD-EE8D-4E78-9E0D-2701156B3A3BQ44064239-3EBB415C-D1F0-4830-9108-A08761E3F4FFQ46352432-88500D3F-5F88-49C7-AC99-27B30B928223Q46824200-03F715FB-B034-4E54-9781-18AC79ED49FAQ48627878-12CE012B-60B2-434D-924C-C057DBCF8C89Q51917535-568446D1-D970-4BFA-8D0F-26007356ACB2
P2860
Lamotrigine inhibition of glutamate release from isolated cerebrocortical nerve terminals (synaptosomes) by suppression of voltage-activated calcium channel activity.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Lamotrigine inhibition of glut ...... ated calcium channel activity.
@en
Lamotrigine inhibition of glutamate release from isolated cerebrocortical nerve terminals
@nl
type
label
Lamotrigine inhibition of glut ...... ated calcium channel activity.
@en
Lamotrigine inhibition of glutamate release from isolated cerebrocortical nerve terminals
@nl
prefLabel
Lamotrigine inhibition of glut ...... ated calcium channel activity.
@en
Lamotrigine inhibition of glutamate release from isolated cerebrocortical nerve terminals
@nl
P2093
P1433
P1476
Lamotrigine inhibition of glut ...... ated calcium channel activity.
@en
P2093
P304
P356
10.1097/00001756-200107200-00042
P577
2001-07-01T00:00:00Z